{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:23:48Z","timestamp":1790346228833,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC1812C"],"award-info":[{"award-number":["RC1812C"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00415-020-10024-0","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T12:02:26Z","timestamp":1593864146000},"page":"3555-3564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Cell-based assays for the detection of MOG antibodies: a comparative study"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-2000","authenticated-orcid":false,"given":"Matteo","family":"Gastaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scaranzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Jarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Zardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Rigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Vegezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Foiadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Savasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Versino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Novi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita Maria","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Annovazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Baroncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Lampasona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"10024_CR1","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.1073\/pnas.90.17.7990","volume":"90","author":"D Pham-Dinh","year":"1993","unstructured":"Pham-Dinh D, Mattei MG, Nussbaum JL et al (1993) Myelin\/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci U S A 90:7990\u20137994. https:\/\/doi.org\/10.1073\/pnas.90.17.7990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10024_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00115-018-0607-0","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflamm 15:134. https:\/\/doi.org\/10.1007\/s00115-018-0607-0","journal-title":"J Neuroinflamm"},{"key":"10024_CR3","first-page":"443","volume":"130","author":"C Linington","year":"1988","unstructured":"Linington C, Bradl M, Lassmann H et al (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein. Am J Pathol 130:443\u2013454","journal-title":"Am J Pathol"},{"key":"10024_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/archneur.56.3.311","volume":"56","author":"A Karni","year":"1999","unstructured":"Karni A, Bakimer-Kleiner R, Abramsky O, Ben-Nun A (1999) Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol 56:311\u2013315. https:\/\/doi.org\/10.1001\/archneur.56.3.311","journal-title":"Arch Neurol"},{"key":"10024_CR5","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/brain\/122.11.2089","volume":"122","author":"RB Lindert","year":"1999","unstructured":"Lindert RB, Haase CG, Brehm U et al (1999) Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122:2089\u20132100. https:\/\/doi.org\/10.1093\/brain\/122.11.2089","journal-title":"Brain"},{"key":"10024_CR6","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/122.11.2047","volume":"122","author":"M Reindl","year":"1999","unstructured":"Reindl M, Linington C, Brehm U et al (1999) Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122:2047\u20132056. https:\/\/doi.org\/10.1093\/brain\/122.11.2047","journal-title":"Brain"},{"key":"10024_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1056\/NEJMoa022328","volume":"349","author":"T Berger","year":"2003","unstructured":"Berger T, Rubner P, Schautzer F et al (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349:139\u2013145. https:\/\/doi.org\/10.1056\/NEJMoa022328","journal-title":"N Engl J Med"},{"key":"10024_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1056\/NEJMoa063602","volume":"356","author":"J Kuhle","year":"2007","unstructured":"Kuhle J, Pohl C, Mehling M et al (2007) Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 356:371\u2013378. https:\/\/doi.org\/10.1056\/NEJMoa063602","journal-title":"N Engl J Med"},{"key":"10024_CR9","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/eji.200425050","volume":"34","author":"HC von B\u00fcdingen","year":"2004","unstructured":"von B\u00fcdingen HC, Hauser SL, Ouallet JC et al (2004) Frontline: Epitope recognition on the myelin\/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol 34:2072\u20132083. https:\/\/doi.org\/10.1002\/eji.200425050","journal-title":"Eur J Immunol"},{"key":"10024_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm1488","volume":"13","author":"KC O\u2019Connor","year":"2007","unstructured":"O\u2019Connor KC, McLaughlin KA, De Jager PL et al (2007) Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13:211\u2013217. https:\/\/doi.org\/10.1038\/nm1488","journal-title":"Nat Med"},{"key":"10024_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","volume":"263","author":"M Sepulveda","year":"2016","unstructured":"Sepulveda M, Armangue T, Martinez-Hernandez E et al (2016) Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol 263:1349\u20131360. https:\/\/doi.org\/10.1007\/s00415-016-8147-7","journal-title":"J Neurol"},{"key":"10024_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 8:184. https:\/\/doi.org\/10.1186\/1742-2094-8-184","journal-title":"J Neuroinflamm"},{"key":"10024_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P (2019) Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15:89\u2013102. https:\/\/doi.org\/10.1038\/s41582-018-0112-x","journal-title":"Nat Rev Neurol"},{"key":"10024_CR14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273\u20131277. https:\/\/doi.org\/10.1212\/WNL.0b013e31826aac4e","journal-title":"Neurology"},{"key":"10024_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Wong YY, Lechner C et al (2018) Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody\u2013Associated disease. JAMA Neurol 75:478\u2013487. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4601","journal-title":"JAMA Neurol"},{"key":"10024_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2940","author":"P Waters","year":"2019","unstructured":"Waters P, Fadda G, Woodhall M et al (2019) Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2940","journal-title":"JAMA Neurol"},{"key":"10024_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflamm 13:279. https:\/\/doi.org\/10.1186\/s12974-016-0717-1","journal-title":"J Neuroinflamm"},{"key":"10024_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflamm 13:280. https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflamm"},{"key":"10024_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. J Neuroinflamm 13:281. https:\/\/doi.org\/10.1186\/s12974-016-0719-z","journal-title":"J Neuroinflamm"},{"key":"10024_CR20","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/wnl.0000000000005560","volume":"90","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E et al (2018) Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology 90:e1858\u2013e1869. https:\/\/doi.org\/10.1212\/wnl.0000000000005560","journal-title":"Neurology"},{"key":"10024_CR21","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR et al (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128\u20133138. https:\/\/doi.org\/10.1093\/brain\/awx276","journal-title":"Brain"},{"key":"10024_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"10024_CR23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J et al (2018) Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75:1355\u20131363. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1814","journal-title":"JAMA Neurol"},{"key":"10024_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0165-5728(00)00462-8","volume":"114","author":"CG Haase","year":"2001","unstructured":"Haase CG, Guggenmos J, Brehm U et al (2001) The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol 114:220\u2013225. https:\/\/doi.org\/10.1016\/S0165-5728(00)00462-8","journal-title":"J Neuroimmunol"},{"key":"10024_CR25","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1073\/pnas.0510672103","volume":"103","author":"PH Lalive","year":"2006","unstructured":"Lalive PH, Menge T, Delarasse C et al (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci USA 103:2280\u20132285. https:\/\/doi.org\/10.1073\/pnas.0510672103","journal-title":"Proc Natl Acad Sci USA"},{"key":"10024_CR26","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0607242103","volume":"103","author":"D Zhou","year":"2006","unstructured":"Zhou D, Srivastava R, Nessler S et al (2006) Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci USA 103:19057\u201319062. https:\/\/doi.org\/10.1073\/pnas.0607242103","journal-title":"Proc Natl Acad Sci USA"},{"key":"10024_CR27","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol NeuroInflammation 2:e89. https:\/\/doi.org\/10.1212\/NXI.0000000000000089","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"10024_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","volume":"138","author":"F Di Pauli","year":"2011","unstructured":"Di Pauli F, Mader S, Rostasy K et al (2011) Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 138:247\u2013254. https:\/\/doi.org\/10.1016\/j.clim.2010.11.013","journal-title":"Clin Immunol"},{"key":"10024_CR29","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1212\/wnl.0000000000007096","volume":"92","author":"PJ Waters","year":"2019","unstructured":"Waters PJ, Komorowski L, Woodhall M et al (2019) A multicenter comparison of MOG-IgG cell-based assays. Neurology 92:e1250\u2013e1255. https:\/\/doi.org\/10.1212\/wnl.0000000000007096","journal-title":"Neurology"},{"key":"10024_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"10024_CR31","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059\u20132069. https:\/\/doi.org\/10.1093\/brain\/120.11.2059","journal-title":"Brain"},{"key":"10024_CR32","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/ene.13922","volume":"26","author":"M Gastaldi","year":"2019","unstructured":"Gastaldi M, De Rosa A, Maestri M et al (2019) Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study. Eur J Neurol 26:992\u2013999. https:\/\/doi.org\/10.1111\/ene.13922","journal-title":"Eur J Neurol"},{"key":"10024_CR33","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","volume":"264","author":"S Mariotto","year":"2017","unstructured":"Mariotto S, Ferrari S, Monaco S et al (2017) Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. J Neurol 264:2420\u20132430. https:\/\/doi.org\/10.1007\/s00415-017-8635-4","journal-title":"J Neurol"},{"key":"10024_CR34","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl M, Schanda K, Woodhall M et al (2020) (2020) International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm 7:e674. https:\/\/doi.org\/10.1212\/NXI.0000000000000674","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10024_CR35","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1212\/nxi.0000000000000404","volume":"4","author":"L McCracken","year":"2017","unstructured":"McCracken L, Zhang J, Greene M et al (2017) Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4:e404. https:\/\/doi.org\/10.1212\/nxi.0000000000000404","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10024_CR36","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters P, Reindl M, Saiz A et al (2016) Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J Neurol Neurosurg Psychiatry 87:1005\u20131015. https:\/\/doi.org\/10.1136\/jnnp-2015-312601","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10024_CR37","doi-asserted-by":"publisher","first-page":"e1867","DOI":"10.1212\/WNL.0000000000008479","volume":"93","author":"S Mariotto","year":"2019","unstructured":"Mariotto S, Gajofatto A, Batzu L et al (2019) Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases. Neurology 93:e1867\u2013e1872. https:\/\/doi.org\/10.1212\/WNL.0000000000008479","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10024-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10024-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10024-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T19:19:21Z","timestamp":1625339961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10024-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10024"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10024-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"GM received honoraria for participation to advisory boards from Roche. The Pavia neuroimmunology laboratory receives payments for antibody assays (MOG, AQP4, and other autoantibodies) The University Hospital and Medical University of Innsbruck (Austria) receives payments for antibody assays (MOG, AQP4, and other autoantibodies) and for MOG and AQP4 antibody validation experiments organized by Euroimmun (L\u00fcbeck, Germany). WP and the University of Oxford hold patents and receive royalties for antibody assays. MOG antibody tests are performed in his laboratory. WP has received speaker or consulting honoraria from Alexion and UBC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The local ethics committee approved this study. All included patients, or their legal representatives, gave written consent for the retrospective analysis of their medical records.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors approved the final version of this document.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}